BRCA2 and acute myeloid leukemia: The MMC-sensitive FA patient-derived AML cell line SB1690CB (BRCA2 mutations IVS7+2T>G and 3827delGT10) was grown in soft gel colony forming assays in the presence of MMC (10–30 nM).